[1] Lee A, et, al. Ansuvimab: First Approval. Drugs. 2021 Apr;81(5):595-598. DOI:
10.1007/s40265-021-01483-4[2] Corti D, et, al. Protective monotherapy against lethal Ebola virus infection by a potently neutralizing antibody. Science. 2016 Mar 18;351(6279):1339-42. DOI:
10.1126/science.aad5224